Indian scientists make drug delivery breakthrough; Biodel touts clinical trial results;

> Biodel touted results from the Phase I clinical trial of its Glucagon Emergency Management (GEM) auto-reconstitution device. Release

> Indian scientists have developed a unique, targeted drug delivery system that focuses on cervical cancer cells without damaging other healthy ones. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.